Drug companies defend rewards to doctors for switching treatmentsBMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7380.67/a (Published 11 January 2003) Cite this as: BMJ 2003;326:67
- Charles Marwick
- Washington, DC
Pharmaceutical companies in the United States have criticised attempts by the government to restrict handouts and promotions to doctors.
Department of Health and Human Services guidelines issued last October warn drug manufacturers against payments or other encouragement, such as entertainment and travel, to doctors and health professionals to switch patients to their own products (BMJ 2002;325:795).
The government is …